Presence of cardiovascular disease is associated with slower cognitive decline in Alzheimer's disease in the absence of cerebrovascular pathology
暂无分享,去创建一个
[1] Wenyaw Chan,et al. Predicting progression of Alzheimer's disease , 2010, Alzheimer's Research & Therapy.
[2] W. Chan,et al. Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease , 2009, Alzheimers Res Ther.
[3] B. Lawlor,et al. Blood pressure and the risk for dementia—A double edged sword , 2009, Ageing Research Reviews.
[4] J. Luchsinger. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. , 2008, European journal of pharmacology.
[5] R. Doody,et al. A method for estimating progression rates in Alzheimer disease. , 2001, Archives of neurology.